HiSQOL-mini: Development and Validation of a Shortened Version of the Hidradenitis Suppurativa Quality of Life (HiSQOL) Instrument

Clicks: 13
ID: 333216
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #389 of 411 articles by views in the british journal of dermatology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 411 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Hidradenitis suppurativa (HS)-specific quality of life (QOL) is one of six core domains for HS studies defined by HIdradenitis SuppuraTiva cORe outcomes set International Collaboration (HISTORIC). The 17-item Hidradenitis Suppurativa Quality of Life (HiSQOL©) questionnaire was developed and validated by HISTORIC to measure this domain. A shortened version would be easier for routine clinical use. Objectives To produce a shortened version of HiSQOL by selecting a subset of the original 17 items. Methods Item selection for HiSQOL-mini was informed by correlation analyses on two datasets from the Treatment of Hidradenitis Suppurativa Evaluation Study (THESEUS) and the BE HEARD I and II Phase 3 trials. Spearman’s rank correlation coefficients were calculated between each item and the HiSQOL total score after omitting that item. Two consensus workshops were then conducted, with patient research partners (PRPs) leading the discussions, to finalise the items for inclusion. Analyses to assess psychometric performance and derive interpretation thresholds for HiSQOL-mini were conducted using the BE HEARD dataset. Results In the symptoms sub-domain, pain exhibited the highest correlation with HiSQOL total score and was unanimously selected at the end of Workshop 1. In the psychosocial sub-domain, the ‘down or depressed’ item performed best from THESEUS data, while the ‘concentration’ and ‘embarrassed’ items performed best from BE HEARD data. Related to content validity, PRPs prioritised ‘down or depressed’ in the discussions. ‘Walking’ performed well in both datasets and PRPs further recommended inclusion of a second activities-adaptations item, ‘getting dressed’. HiSQOL-mini demonstrated good validity, reliability and responsiveness, and has scores ranging from 0–16. Minimal important difference was a 3-point reduction and clinically meaningful change was a 5-point reduction. Severity thresholds for HiSQOL-mini score were 0 for ‘none’, 1–2 for ‘mild’, 3–4 for ‘moderate’, 5–6 for ‘severe’ and 7–16 for ‘very severe’. Conclusions HiSQOL-mini, using the same item format as HiSQOL, contains four items relating to ‘pain’, feeling ‘down or depressed’, ‘walking’ and ‘getting dressed’. HiSQOL-mini is a valid, reliable and responsive questionnaire to measure health-related QOL in patients with HS and should be swift to perform.
Reference Key
openalex_W7223085201 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors John Robert Ingram, Jasmine I. Espy, Amit Garg, Angela Gibbons, Athena Gierbolini, Samar Hasan, Gregor B. E. Jemec, Joslyn S. Kirby, Barry M. McGrath, Timothy Pickles, Jerry Tan, Linnea Thorlacius, Jérémy Lambert, Rhys Warham, Bente Villumsen
Are you one of these authors? Claim your profile
Journal the british journal of dermatology
Year 2026
DOI
10.1093/bjd/ljag468
URL
https://doi.org/10.1093/bjd/ljag468
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.